{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:30:31Z","timestamp":1783636231073,"version":"3.55.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:p>Diabetes mellitus is chronic disease with increasing prevalence, and may cause many organ complications, including kidneys. Reduced creatinine clearance and kidney failure are important, but hyperkalemia may be present in diabetic patients even before these problems. There may be many reasons of hyperkalemia in this group of patients. Type IV renal tubular acidosis is important cause of generally mild hyperkalemia, and it is a treatable condition. \u2018\u2018Polypharmacy\u2019\u2019 \u2013which is very common in diabetic patients due to accompanying other diseases- may trigger electrolyte imbalance. Underlying causes should be investigated and treatment should be done before it worsens.<\/jats:p>","DOI":"10.3389\/fcdhc.2025.1570868","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:10:27Z","timestamp":1752207027000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Underestimated reason of hyperkalemia in diabetic patients: type IV renal tubular acidosis- mini review"],"prefix":"10.3389","volume":"6","author":[{"given":"Sibel","family":"Ertek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayser","family":"Caglar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"B1","first-page":"S97","article-title":"Potassium transport\u2013an update","author":"Giebisch","year":"2010","journal-title":"J. Nephrol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ki.1980.14","article-title":"Hyperkalemia and hyporeninemic hypoaldosteronism","volume":"17","author":"DeFronzo","year":"1980","journal-title":"Kidney Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1097\/01.asn.0000023430.92674.e5","article-title":"Renal tubular acidosis: the clinical entity","volume":"13","author":"Rodr\u00edguez Soriano","year":"2002","journal-title":"J. Am. Soc. Nephrol"},{"key":"B4","article-title":"Review of the diagnostic evaluation of renal tubular acidosis","volume":"16","author":"Yaxley","year":"2016","journal-title":"Ochsner J"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2018.05.004","article-title":"Hyperkalemic forms of renal tubular acidosis: clinical and pathophysiological aspects","volume":"25","author":"Battle","year":"2018","journal-title":"Adv. Chronic Kidney Dis"},{"key":"B6","article-title":"Renal tubular acidosis","author":"Mustaqeem","year":"2023","journal-title":"StatPearls"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9312481","DOI":"10.1155\/2017\/9312481","article-title":"Tacrolimus-induced type IV renal tubular acidosis following liver transplantation","volume":"2017","author":"Schmoyer","year":"2017","journal-title":"Case Rep. Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/0961203315603143","article-title":"Renal tubular acidosis type IV as a complication of lupus nephritis","volume":"25","author":"Sanchez-Marcos","year":"2016","journal-title":"Lupus"},{"key":"B9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1752-1947-5-114","article-title":"Systemic lupus erythematosus associated with type 4 renal tubular acidosis: a case report and review of the literat\u00fcre","volume":"5","author":"Porteous","year":"2011","journal-title":"J. Med. Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2015.08.008","article-title":"Type 4 renal tubular acidosis in a kidney transplant recipient","volume":"39","author":"Kulkarni","year":"2016","journal-title":"BioMed. J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12485","article-title":"Clinical analysis of\u00a0hyperkalemic renal tubular acidosis caused by calcineurin inhibitors in solid organ transplant recipients","volume":"42","author":"Lin","year":"2017","journal-title":"J. Clin. Pharm. Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v7.i5.101","article-title":"Hyporeninemic\u00a0hypoaldosteronism and diabetes mellitus: Pathophysiology assumptions, clinical aspects and implications for management","volume":"7","author":"Sousa","year":"2016","journal-title":"World J. Diabetes"},{"key":"B13","article-title":"Disorders of potassium homeostasis: pathophysiology and management","volume":"56","author":"Hoskote","year":"2008","journal-title":"J. Assoc Physicians India"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008020166","article-title":"Mechanisms in hyperkalemic renal tubular acidosis","volume":"20","author":"Karet","year":"2009","journal-title":"J. Am. Soc. Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/ki.1980.11","article-title":"Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency","volume":"17","author":"Schambelan","year":"1980","journal-title":"Kidney Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903152045","article-title":"ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trial","volume":"25","author":"D\u00fcsing","year":"2009","journal-title":"Curr.\u00a0Med. Res. Opin"},{"key":"B17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3810\/pgm.2009.05.2000","article-title":"Renin-angiotensin-aldosterone system blockade in diabetes: role of direct renin inhibitors","volume":"121","author":"Estacio","year":"2009","journal-title":"Postgrad Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/1470320309342733","article-title":"Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension","volume":"17","author":"Doulton","year":"2009","journal-title":"J. Renin Angiotensin Aldosterone Syst"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-019-0727-7","article-title":"Clinical features, genetic background, and outcome in infants with urinary tract infection and type IV renal tubular acidosis","volume":"87","author":"Tseng","year":"2020","journal-title":"Pediatr. Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-023-06079-6","article-title":"Hyporeninemic hypoaldosteronism in RMND1-related mitochondrial disease","volume":"39","author":"Komhoff","year":"2024","journal-title":"Pediatr. Nephrol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/imj.1970.19.4.287","article-title":"Hypertension and severe hyperkalaemia associated with supression of renin and aldosterone and completely reversed by dietartuy sodium restriction","volume":"19","author":"Gordon","year":"1970","journal-title":"Australas. Ann. Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1126\/science.1062844","article-title":"Human hypertension caused by mutations in WNK kinases","volume":"293","author":"Wison","year":"2001","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature10814","article-title":"Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities","volume":"482","author":"Boyden","year":"2012","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/966","article-title":"Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I","volume":"19","author":"Geller","year":"1998","journal-title":"Nat. Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1210\/jc.2002-021932","article-title":"Different inactivating mutations of the mineralocorticoid receptor in fourteen familiesaffected by type I pseudohypoaldosteronism","volume":"88","author":"Sartorato","year":"2003","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"B27","article-title":"Relationship between hyporeninemic hypoaldosteronism nephyropathy and autonomic neuropathy in diabetes mellitus","volume":"72","author":"Sughiyama","year":"1983","journal-title":"Nihon Naika Gakkai Zassi"},{"key":"B28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/diseases10020020","article-title":"Hyperkalemia in diabetes mellitus setting","volume":"10","author":"Goia-Nishide","year":"2022","journal-title":"Diseases"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04446.x","article-title":"Renal tubular acidosis type IV in hyperkalaemic patients\u2013a fairy tale or reality","volume":"78","author":"Haas","year":"2013","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5935\/0101-2800.20170086","article-title":"Diabetes mellitus and hyperkalemic renal tubular acidosis: case reports and literature review","volume":"39","author":"Bello","year":"2017","journal-title":"J. Bras Nefrol"},{"key":"B31","unstructured":"2025"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1570868\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:10:29Z","timestamp":1752207029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2025.1570868\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":31,"alternative-id":["10.3389\/fcdhc.2025.1570868"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2025.1570868","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"article-number":"1570868"}}